134 related articles for article (PubMed ID: 23199820)
1. Commentary: Retrograde ejaculation and the use of rhBMP-2 for anterior lumbar interbody fusion: what does the evidence say to surgeons and to patients?
Mroz TE; Abdullah KG; Benzel EC
Spine J; 2012 Oct; 12(10):891-3. PubMed ID: 23199820
[No Abstract] [Full Text] [Related]
2. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
[TBL] [Abstract][Full Text] [Related]
3. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
Burkus JK; Dryer RF; Peloza JH
J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
[TBL] [Abstract][Full Text] [Related]
4. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of retrograde ejaculation using semen analysis, comparison with a standardized qualitative questionnaire, and investigating the impact of rhBMP-2.
Tepper G; Rabbani R; Yousefzadeh M; Prince D
Spine (Phila Pa 1976); 2013 May; 38(10):841-5. PubMed ID: 23403551
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Recombinant human bone morphogenetic protein-2.
Shaffrey CI; Smith JS
J Neurosurg Spine; 2013 Feb; 18(2):109-10; discussion 110-1. PubMed ID: 23198758
[No Abstract] [Full Text] [Related]
7. An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.
Smoljanovic T; Bojanic I
Spine J; 2011 Jun; 11(6):520-1. PubMed ID: 21612986
[No Abstract] [Full Text] [Related]
8. Another complication associated with rhBMP-2?
Kang JD
Spine J; 2011 Jun; 11(6):517-9. PubMed ID: 21612984
[No Abstract] [Full Text] [Related]
9. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
[TBL] [Abstract][Full Text] [Related]
10. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article.
Lubelski D; Abdullah KG; Nowacki AS; Alvin MD; Steinmetz MP; Chakka S; Li Y; Gajewski N; Benzel EC; Mroz TE
J Neurosurg Spine; 2013 Feb; 18(2):126-31. PubMed ID: 23231356
[TBL] [Abstract][Full Text] [Related]
11. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
[TBL] [Abstract][Full Text] [Related]
12. Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons.
Rodgers SD; Marascalchi BJ; Grobelny BT; Smith ML; Samadani U
J Neurosurg Spine; 2013 Jun; 18(6):582-7. PubMed ID: 23560709
[TBL] [Abstract][Full Text] [Related]
13. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.
Tannoury CA; An HS
Spine J; 2014 Mar; 14(3):552-9. PubMed ID: 24412416
[TBL] [Abstract][Full Text] [Related]
14. Seroma observed 6 months after anterior lumbar interbody fusion that included use of recombinant bone morphogenetic protein 2.
Scheer JK; Dahdaleh NS; Smith ZA
Spine J; 2015 Oct; 15(10):e33. PubMed ID: 26022670
[No Abstract] [Full Text] [Related]
15. Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2.
Lehman RA; Kang DG
Spine J; 2012 Jun; 12(6):530-1. PubMed ID: 22682741
[No Abstract] [Full Text] [Related]
16. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
Carragee EJ; Hurwitz EL; Weiner BK
Spine J; 2011 Jun; 11(6):471-91. PubMed ID: 21729796
[TBL] [Abstract][Full Text] [Related]
17. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
[TBL] [Abstract][Full Text] [Related]
18. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
19. Ectopic bone formation with joint impingement after posterior lumbar fusion with rhBMP-2.
Bannwarth M; Kleiber JC; Marlier B; Eap C; Duntze J; Litre CF
Orthop Traumatol Surg Res; 2016 Apr; 102(2):255-6. PubMed ID: 26947733
[TBL] [Abstract][Full Text] [Related]
20. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
